本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Fortress Biotech Inc Series A P

18.28
-0.0196-0.11%
成交量:1.17萬
成交額:21.28萬
市值:6,264.91萬
市盈率:6.90
高:18.50
開:18.50
低:18.15
收:18.30
52周最高:21.43
52周最低:6.27
股本:342.71萬
流通股本:342.71萬
量比:1.01
換手率:0.34%
股息:- -
股息率:- -
每股收益(TTM):2.65
每股收益(LYR):-2.6890
淨資產收益率:-746.25%
總資產收益率:-32.37%
市淨率:2.82
市盈率(LYR):-6.80

資料載入中...

2024/01/27

重要事件披露

Form 8-K - Current report
2024/01/03

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/03

重要事件披露

Form 8-K - Current report
2023/11/21

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/21

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/14

重要事件披露

Form 8-K - Current report
2023/11/14

重要事件披露

Form 8-K - Current report
2023/11/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/10/27

SEC問詢函

Form CORRESP - Correspondence
2023/10/26

重要事件披露

Form 8-K - Current report
2023/10/11

重要事件披露

Form 8-K - Current report
2023/09/30

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/09/30

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/09/27

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/09/19

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/08/14

重要事件披露

Form 8-K - Current report
2023/08/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/07/19

SEC問詢函

Form CORRESP - Correspondence
2023/07/06

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/06/23

重要事件披露

Form 8-K - Current report